Want to join the conversation?
In 3Q15, $BXLT reported earnings on a GAAP basis of $309MM & $0.45 per diluted share including net after-tax special items of $76MM, or $0.11 per share. On an adjusted pro forma basis, excluding special items, $BXLT reported earnings of $385MM & $0.56 per diluted share, exceeding its previously-issued guidance of $0.48-0.50 per diluted share.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)